Invesa AG and Inphasearch AG agreed to acquire 34.9% stake in Sanochemia Pharmazeutika AG (XTRA:SAC) from Sanochemia Ltd. on February 22, 2016. Invesa AG will hold 14% stake and Inphasearch AG will hold 20.9% stake in Sanochemia Pharmazeutika on closing.
1st Jan change | Capi. | |
---|---|---|
+9.85% | 72.5B | |
+13.69% | 9.11B | |
-12.85% | 5.07B | |
+60.16% | 5.01B | |
+1.60% | 3.85B | |
-19.20% | 2.46B | |
+18.65% | 2.44B | |
+24.62% | 2.27B | |
-27.46% | 2.26B |